Pfizer

Czar of innovation & marketing: Apple, the USD 2-trillion-worth brand

Czar of innovation & marketing: Apple, the USD 2-trillion-worth brand

Recently, Apple became the first US (and the World’s) first company to cross USD 2 trillion in valuation powered by the relentless rise i...Read More

COVID-19 impact: Pfizer's profit drops by 32%

COVID-19 impact: Pfizer's profit drops by 32%

Pfizer reported a 32 per cent plunge in second-quarter profit, mainly due to the global coronavirus pandemic limiting marketing of and ne...Read More

Six COVID-19 vaccines that are showing the most promise

Six COVID-19 vaccines that are showing the most promise

It is estimated that there are around 110 vaccine candidates under development of which only eight have so far reached the clinical study...Read More

German company begins testing possible vaccine

German company begins testing possible vaccine

BioNTech, which is working with U.S.-based Pfizer, said Wednesday that 12 participants of a clinical trial in Germany have received doses...Read More

Pfizer denies report that Irish sheep drank Viagra and had a sex orgy

Pfizer denies report that Irish sheep drank Viagra and had a sex orgy

Drug manufacturer Pfizer on Wednesday denied a report which claimed that hundreds of sheep in Southern Ireland went on a week-long uncont...Read More

Pfizer Q2 rises 61% to Rs 154.25 cr

Pfizer Q2 rises 61% to Rs 154.25 cr

New Delhi: Pharma firm Pfizer Ltd on Saturday reported a 61.01 per cent rise in net profit to Rs 154.25 crore for the July-September quar...Read More

GSK, Pfizer consumer healthcare joint venture formation approved

GSK, Pfizer consumer healthcare joint venture formation approved

New Delhi: The Competition Commission (CCI) said it has approved the formation of a joint venture for consumer healthcare products by pha...Read More

placeholder

Piramal buys 4 Pfizer brands for Rs 110 cr

New Delhi: Ajay Piramal-led Piramal Enterprises has entered into an agreement to acquire four brands from Pfizer for a consideration of R...Read More

placeholder

India rejects Pfizer’s patent application for arthritis drug

New Delhi :  India’s patent office has again rejected US drug major Pfizer’s new patent application for its rheumatoid arthritis medicine...Read More

Free Press Journal

www.freepressjournal.in